|
1
|
Cheregi MC, Tirsoaga A, Ion C, Iorgulescu
EE, David IG and Noor H: Curcumin electroanalysis at a disposable
graphite electrode. Biosensors (Basel). 15:1372025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Monton C, Chuanchom P, Popanit P,
Settharaksa S and Pathompak P: Simplex lattice design for
optimization of the mass ratio of Curcuma longa L., Curcuma
zedoaria (Christm.) Roscoe and Curcuma aromatica Salisb. to
maximize curcuminoids content and antioxidant activity. Acta Pharm.
71:445–457. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abdul-Rahman T, Awuah WA, Mikhailova T,
Kalmanovich J, Mehta A, Ng JC, Coghlan MA, Zivcevska M, Tedeschi
AJ, de Oliveira EC, et al: Antioxidant, anti-inflammatory and
epigenetic potential of curcumin in Alzheimer's disease.
Biofactors. 50:693–708. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao F, Liang W, Chen Q, Chen B, Liu Y, Liu
Z, Xu X, Zhu R and Cheng L: A curcumin-decorated nanozyme with ros
scavenging and anti-inflammatory properties for neuroprotection.
Nanomaterials (Basel). 14:3892024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyazaki K, Xu C, Shimada M and Goel A:
Curcumin and andrographis exhibit anti-tumor effects in colorectal
cancer via activation of ferroptosis and dual suppression of
glutathione peroxidase-4 and ferroptosis suppressor protein-1.
Pharmaceuticals (Basel). 16:3832023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li M, Guo T, Lin J, Huang X, Ke Q, Wu Y,
Fang C and Hu C: Curcumin inhibits the invasion and metastasis of
triple negative breast cancer via Hedgehog/Gli1 signaling pathway.
J Ethnopharmacol. 283:1146892022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Yang J, Gong Y, He S, Wen P,
Jiang Y, He J, Zhu B and Li L: In vitro and in vivo supplementation
with curcumin promotes hippocampal neuronal synapses development in
rats by inhibiting GSK-3β and activating β-catenin. Mol Neurobiol.
61:2390–2410. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aktaş A, Yiğit F, Delibaş B, Kaplan AA,
Hamour HM, Marangoz AH, Kaya A, Altun G and Kaplan S: The effects
of Garcinia kola and curcumin on the dorsal root ganglion of the
diabetic rat after peripheral nerve transection injury. J Chem
Neuroanat. 136:1023952024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, Hua B, He Q, Han Z, Wang Y, Chen
Y, Ni H, Zhu Z, Xu L, Yao M and Ni C: Curcumin analogue NL04
inhibits spinal cord central sensitization in rats with bone cancer
pain by inhibiting NLRP3 inflammasome activation and reducing IL-1β
production. Eur J Pharmacol. 970:1764802024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan X, Huang J, Zhang W, Su Z, Li J, Wu Z
and Zhang P: A multifunctional, tough, stretchable, and transparent
curcumin hydrogel with potent antimicrobial, antioxidative,
anti-inflammatory, and angiogenesis capabilities for diabetic wound
healing. ACS Appl Mater Interfaces. 16:9749–9767. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Wei N, Wei J, Fang C, Feng T, Liu F,
Liu X and Wu B: Curcumin and silver nanoparticles loaded
antibacterial multifunctional pectin/gelatin films for food
packaging applications. Int J Biol Macromol. 266((Pt 1)):
1312482024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu XY, Meng X, Li S, Gan RY, Li Y and Li
HB: Bioactivity, health benefits, and related molecular mechanisms
of curcumin: Current progress, challenges, and perspectives.
Nutrients. 10:15532018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuda T: Curcumin as a functional
food-derived factor: Degradation products, metabolites,
bioactivity, and future perspectives. Food Funct. 9:705–714. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heger M, van Golen RF, Broekgaarden M and
Michel MC: The molecular basis for the pharmacokinetics and
pharmacodynamics of curcumin and its metabolites in relation to
cancer. Pharmacol Rev. 66:222–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Zhong Y, Yan LN, Sun X, Gong T
and Zhang ZR: Synthesis and preliminary evaluation of curcumin
analogues as cytotoxic agents. Bioorg Med Chem Lett. 21:1010–1014.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chainoglou E and Hadjipavlou-Litina D:
Curcumin in health and diseases: Alzheimer's disease and curcumin
analogues, derivatives, and hybrids. Int J Mol Sci. 21:19752020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moreno-Q G, Herrera-R A, Yepes AF, Naranjo
TW and Cardona-G W: Proapoptotic effect and molecular docking
analysis of curcumin-resveratrol hybrids in colorectal cancer
chemoprevention. Molecules. 27:34862022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moreno-Quintero G, Betancur-Zapata E,
Herrera-Ramírez A and Cardona-Galeano W: New hybrid scaffolds based
on 5-FU/Curcumin: Synthesis, cytotoxic, antiproliferative and
pro-apoptotic effect. Pharmaceutics. 15:12212023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang JQ, Wang X, Wang Y, Tang WJ, Shi JB
and Liu XH: Novel curcumin analogue hybrids: Synthesis and
anticancer activity. Eur J Med Chem. 156:493–509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Al-Thubaiti EH: Antibacterial and
antioxidant activities of curcumin/Zn metal complex with its
chemical characterization and spectroscopic studies. Heliyon.
9:e174682023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sethiya A, Agarwal DK and Agarwal S:
Current trends in drug delivery system of curcumin and its
therapeutic applications. Mini Rev Med Chem. 20:1190–1232. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jagannathan R, Abraham PM and Poddar P:
Temperature-dependent spectroscopic evidences of curcumin in
aqueous medium: A mechanistic study of its solubility and
stability. J Phys Chem B. 116:14533–14540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leung MHM, Addicoat MA, Lincoln SF, Metha
GF and Kee TW: Time-resolved keto-enol tautomerization of the
medicinal pigment curcumin. Phys Chem Chem Phys. 26:14970–14979.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kharat M, Du Z, Zhang G and McClements DJ:
Physical and chemical stability of curcumin in aqueous solutions
and emulsions: Impact of pH, temperature, and molecular
environment. J Agric Food Chem. 65:1525–1532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lestari ML and Indrayanto G: Curcumin.
Profiles Drug Subst Excip Relat Methodol. 39:113–204. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burapan S, Kim M and Han J: Curcuminoid
demethylation as an alternative metabolism by human intestinal
microbiota. J Agric Food Chem. 65:3305–3310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Somparn P, Phisalaphong C, Nakornchai S,
Unchern S and Morales NP: Comparative antioxidant activities of
curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm
Bull. 30:74–78. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jude S, Amalraj A, Kunnumakkara AB, Divya
C, Löffler BM and Gopi S: Development of validated methods and
quantification of curcuminoids and curcumin metabolites and their
pharmacokinetic study of oral administration of complete natural
turmeric formulation (Cureit™) in human plasma via
UPLC/ESI-Q-TOF-MS spectrometry. Molecules. 23:24152018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morales NP, Sirijaroonwong S, Yamanont P
and Phisalaphong C: Electron paramagnetic resonance study of the
free radical scavenging capacity of curcumin and its demethoxy and
hydrogenated derivatives. Biol Pharm Bull. 38:1478–1483. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Girst G, Ötvös SB, Fülöp F, Balogh GT and
Hunyadi A: Pharmacokinetics-driven evaluation of the antioxidant
activity of curcuminoids and their major reduced metabolites-A
medicinal chemistry approach. Molecules. 26:35422021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang ZB, Luo DD, Xie JH, Xian YF, Lai ZQ,
Liu YH, Liu WH, Chen JN, Lai XP, Lin ZX and Su ZR: Curcumin's
metabolites, tetrahydrocurcumin and octahydrocurcumin, possess
superior anti-inflammatory effects in vivo through suppression of
TAK1-NF-κB pathway. Front Pharmacol. 9:11812018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Almalki Z, Algregri M, Alhosin M, Alkhaled
M, Damiati S and Zamzami MA: In vitro cytotoxicity of curcuminoids
against head and neck cancer HNO97 cell line. Braz J Biol.
83:e2487082021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen CY, Lien JC, Chen CY, Hung CC and Lin
HC: Design, synthesis and evaluation of novel derivatives of
curcuminoids with cytotoxicity. Int J Mol Sci. 22:121712021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pratti VL, Thomas M, Bhoite R and
Satyavrat V: Investigating bioavailability of curcumin and piperine
combination in comparison to turmeric rhizomes: An in vitro study.
J Exp Pharmacol. 16:37–47. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Iglesias DE, Cremonini E, Oteiza PI and
Fraga CG: Curcumin mitigates TNFα-induced Caco-2 cell monolayer
permeabilization through modulation of NF-κB, ERK1/2, and JNK
pathways. Mol Nutr Food Res. 66:e21010332022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang Y, Cao S, Zhang Q, Zhang H, Fan Y,
Qiu F and Kang N: Biological and pharmacological effects of
hexahydrocurcumin, a metabolite of curcumin. Arch Biochem Biophys.
646:31–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schmitt F, Subramaniam D, Anant S, Padhye
S, Begemann G, Schobert R and Biersack B: Halogenated
Bis(methoxybenzylidene)-4-piperidone curcuminoids with improved
anticancer activity. ChemMedChem. 13:1115–1123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang L, Gou S, Liu X, Cao F and Cheng L:
Design, synthesis and anti-Alzheimer properties of
dimethylaminomethyl-substituted curcumin derivatives. Bioorg Med
Chem Lett. 24:40–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Feng JY and Liu ZQ: Phenolic and enolic
hydroxyl groups in curcumin: Which plays the major role in
scavenging radicals? J Agric Food Chem. 57:11041–11046. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fang X, Fang L, Gou S and Cheng L: Design
and synthesis of dimethylaminomethyl-substituted curcumin
derivatives/analogues: Potent antitumor and antioxidant activity,
improved stability and aqueous solubility compared with curcumin.
Bioorg Med Chem Lett. 23:1297–1301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cui L, Wang S, Zhang J, Wang M, Gao Y, Bai
L, Zhang H, Ma G and Ba X: Effect of curcumin derivatives on hen
egg white lysozyme amyloid fibrillation and their interaction study
by spectroscopic methods. Spectrochim Acta A Mol Biomol Spectrosc.
223:1173652019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang M, Liu J, Fan Y, Sun J, Cheng JX,
Zhang XF, Zhai BT and Guo DY: Development of curcumin-loaded
galactosylated chitosan-coated nanoparticles for targeted delivery
of hepatocellular carcinoma. Int J Biol Macromol. 253((Pt 6)):
1272192023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liang G, Shao L, Wang Y, Zhao C, Chu Y,
Xiao J, Zhao Y, Li X and Yang S: Exploration and synthesis of
curcumin analogues with improved structural stability both in vitro
and in vivo as cytotoxic agents. Bioorg Med Chem. 17:2623–2631.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang J, Feng Z, Wang C, Zhou H, Liu W,
Kanchana K, Dai X, Zou P, Gu J, Cai L and Liang G: Curcumin
derivative WZ35 efficiently suppresses colon cancer progression
through inducing ROS production and ER stress-dependent apoptosis.
Am J Cancer Res. 7:275–288. 2017.PubMed/NCBI
|
|
45
|
Subhedar DD, Shaikh MH, Nawale L, Sarkar
D, Khedkar VM and Shingate BB: Quinolidene based monocarbonyl
curcumin analogues as promising antimycobacterial agents: Synthesis
and molecular docking study. Bioorg Med Chem Lett. 27:922–928.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cao W, Yu P, Cao Y, Feng S and Yin N:
Synthesis and antitumor evaluation of amino acid conjugates of
monocarbonyl curcumin in hepatocellular carcinoma cell. Sci Rep.
15:81812025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wen J, Zhao L, Li Z, Pi C, Feng X, Shi P,
Yang H, Chen L, Wang X, Liu F, et al: Preparation and anti-colon
cancer effect of a novel curcumin analogue (CA8): In vivo and in
vitro evaluation. Front Pharmacol. 15:14646262024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Clariano M, Marques V, Vaz J, Awam S,
Afonso MB, Perry MJ and Rodrigues CMP: Monocarbonyl analogs of
curcumin with potential to treat colorectal cancer. Chem Biodivers.
20:e2023002222023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mathur P, Mori M, Vyas H, Mor K, Jagtap J,
Vadher S, Vyas K, Devkar R and Desai A: Synthesis of novel
Bis-imino and Bis-amino curcuminoids for evaluation of their
anticancer and antibacterial activity. ACS Omega. 7:45545–45555.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Banuppriya G, Sribalan R, Padmini V and
Shanmugaiah V: Biological evaluation and molecular docking studies
of new curcuminoid derivatives: Synthesis and characterization.
Bioorg Med Chem Lett. 26:1655–1659. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kotani R, Urano Y and Sugimoto Noguchi N:
Decrease of amyloid-β levels by curcumin derivative via modulation
of amyloid-β protein precursor trafficking. J Alzheimers Dis.
56:529–542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang Q, Hui M, Chen G, Huang H, Wang S,
Ye Y, Wang Y, Wang M, Zhang S, Huang L, et al:
Curcumin-Piperlongumine hybrid molecule increases cell cycle arrest
and apoptosis in lung cancer through JNK/c-Jun signaling pathway. J
Agric Food Chem. 72:7244–7255. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Corrêa RLGQ, de Moraes MMF, de Oliveira
KT, Aoto YA, Coutinho-Neto MD and Homem-de-Mello P: Diving into the
optoelectronic properties of Cu(II) and Zn(II) curcumin complexes:
A DFT and wavefunction benchmark. J Mol Model. 29:1662023.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sareen R, Jain N and Dhar KL:
Curcumin-Zn(II) complex for enhanced solubility and stability: An
approach for improved delivery and pharmacodynamic effects. Pharm
Dev Technol. 21:630–635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Valentini A, Conforti F, Crispini A, De
Martino A, Condello R, Stellitano C, Rotilio G, Ghedini M, Federici
G, Bernardini S and Pucci D: Synthesis, oxidant properties, and
antitumoral effects of a heteroleptic palladium(II) complex of
curcumin on human prostate cancer cells. J Med Chem. 52:484–491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
John VD, Ummathur MB and Krishnankutty K:
Synthesis, characterization, and antitumour studies of some
curcuminoid analogues and their aluminum complexes. J Coord Chem.
66:1508–1518. 2013. View Article : Google Scholar
|
|
57
|
Pucci D, Crispini A, Mendiguchía BS,
Pirillo S, Ghedini M, Morelli S and De Bartolo L: Improving the
bioactivity of Zn(II)-curcumin based complexes. Dalton Trans.
42:9679–9687. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu X, Wu Z, Guo C, Guo H, Su Y, Chen Q,
Sun C, Liu Q, Chen D and Mu H: Hypoxia responsive nano-drug
delivery system based on angelica polysaccharide for liver cancer
therapy. Drug Deliv. 29:138–148. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
De Leo V, Milano F, Mancini E, Comparelli
R, Giotta L, Nacci A, Longobardi F, Garbetta A, Agostiano A and
Catucci L: Encapsulation of curcumin-loaded liposomes for colonic
drug delivery in a pH-responsive polymer cluster using a pH-driven
and organic solvent-free process. Molecules. 23:7392018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nikolić L, Urošević M, Nikolić V, Gajić I,
Dinić A, Miljković V, Rakić S, Đokić S, Kesić J, Ilić-Stojanović S
and Nikolić G: The formulation of curcumin:
2-hydroxypropyl-β-cyclodextrin complex with smart hydrogel for
prolonged release of curcumin. Pharmaceutics. 15:3822023.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tan KX, Ng LE and Loo SCJ: Formulation
development of a food-graded curcumin-loaded medium chain
triglycerides-encapsulated kappa carrageenan (CUR-MCT-KC) gel bead
based oral delivery formulation. Materials (Basel). 14:27832021.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wu MF, Huang YH, Chiu LY, Cherng SH, Sheu
GT and Yang TY: Curcumin induces apoptosis of chemoresistant lung
cancer cells via ROS-regulated p38 MAPK phosphorylation. Int J Mol
Sci. 23:82482022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhi TX, Liu KQ, Cai KY, Zhao YC, Li ZW,
Wang X, He XH and Sun XY: Anti-Lung cancer activities of
1,2,3-triazole curcumin derivatives via regulation of the
MAPK/NF-κB/STAT3 signaling pathways. ChemMedChem.
17:e2021006762022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tung CL, Jian YJ, Chen JC, Wang TJ, Chen
WC, Zheng HY, Chang PY, Liao KS and Lin YW: Curcumin downregulates
p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1)
expression to enhance cisplatin-induced cytotoxicity in human lung
cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 389:657–666.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lee J, Im YH, Jung HH, Kim JH, Park JO,
Kim K, Kim WS, Ahn JS, Jung CW, Park YS, et al: Curcumin inhibits
interferon-alpha induced NF-kappaB and COX-2 in human A549
non-small cell lung cancer cells. Biochem Biophys Res Commun.
334:313–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kashyap VK, Nagesh PKB, Singh AK, Massey
A, Darkwah GP, George A, Khan S, Hafeez BB, Zafar N, Kumar S, et
al: Curcumin attenuates smoking and drinking activated NF-κB/IL-6
inflammatory signaling axis in cervical cancer. Cancer Cell Int.
24:3432024. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang JY, Wang X, Wang XJ, Zheng BZ, Wang
Y, Wang X and Liang B: Curcumin inhibits the growth via
Wnt/β-catenin pathway in non-small-cell lung cancer cells. Eur Rev
Med Pharmacol Sci. 22:7492–7499. 2018.PubMed/NCBI
|
|
68
|
Petiti J, Rosso V, Lo Iacono M, Panuzzo C,
Calabrese C, Signorino E, Pironi L, Cartellà A, Bracco E,
Pergolizzi B, et al: Curcumin induces apoptosis in JAK2-mutated
cells by the inhibition of JAK2/STAT and mTORC1 pathways. J Cell
Mol Med. 23:4349–4357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Feng C, Xia Y, Zou P, Shen M, Hu J, Ying
S, Pan J, Liu Z, Dai X, Zhuge W, et al: Curcumin analog L48H37
induces apoptosis through ROS-mediated endoplasmic reticulum stress
and STAT3 pathways in human lung cancer cells. Mol Carcinog.
56:1765–1777. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Alexandrow MG, Song LJ, Altiok S, Gray J,
Haura EB and Kumar NB: Curcumin: A novel Stat3 pathway inhibitor
for chemoprevention of lung cancer. Eur J Cancer Prev. 21:407–412.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wu L, Guo L, Liang Y, Liu X, Jiang L and
Wang L: Curcumin suppresses stem-like traits of lung cancer cells
via inhibiting the JAK2/STAT3 signaling pathway. Oncol Rep.
34:3311–3317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Xu X and Zhu Y: Curcumin inhibits human
non-small cell lung cancer xenografts by targeting STAT3 pathway.
Am J Transl Res. 9:3633–3641. 2017.PubMed/NCBI
|
|
74
|
Shi HS, Gao X, Li D, Zhang QW, Wang YS,
Zheng Y, Cai LL, Zhong RM, Rui A, Li ZY, et al: A systemic
administration of liposomal curcumin inhibits radiation pneumonitis
and sensitizes lung carcinoma to radiation. Int J Nanomedicine.
7:2601–2611. 2012.PubMed/NCBI
|
|
75
|
Zhang L, Tao X, Fu Q, Ge C, Li R, Li Z,
Zhu Y, Tian H, Li Q, Liu M, et al: Curcumin inhibits cell
proliferation and migration in NSCLC through a synergistic effect
on the TLR4/MyD88 and EGFR pathways. Oncol Rep. 42:1843–1855.
2019.PubMed/NCBI
|
|
76
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
77
|
Cho HK, Park CG and Lim HB: Construction
of a synergy combination model for turmeric (Curcuma longa
L.) and Black Pepper (Piper nigrum L.) extracts: Enhanced
anticancer activity against A549 and NCI-H292 human lung cancer
cells. Curr Issues Mol Biol. 46:5551–5560. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tsai JR, Liu PL, Chen YH, Chou SH, Cheng
YJ, Hwang JJ and Chong IW: Curcumin inhibits non-small cell lung
cancer cells metastasis through the Adiponectin/NF-κb/MMPs
signaling pathway. PLoS One. 10:e01444622015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Pi C, Zhao W, Zeng M, Yuan J, Shen H, Li
K, Su Z, Liu Z, Wen J, Song X, et al: Anti-lung cancer effect of
paclitaxel solid lipid nanoparticles delivery system with curcumin
as co-loading partner in vitro and in vivo. Drug Deliv.
29:1878–1891. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W,
Yang D, Yang A and Yu Y: Antitumor activity of curcumin by
modulation of apoptosis and autophagy in human lung cancer A549
cells through inhibiting PI3K/Akt/mTOR pathway. Oncol Rep.
39:1523–1531. 2018.PubMed/NCBI
|
|
81
|
Wang N, Feng T, Liu X and Liu Q: Curcumin
inhibits migration and invasion of non-small cell lung cancer cells
through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR
signaling pathway. Acta Pharm. 70:399–409. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Jiao D, Wang J, Lu W, Tang X, Chen J, Mou
H and Chen QY: Curcumin inhibited HGF-induced EMT and angiogenesis
through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways
in lung cancer. Mol Ther Oncolytics. 3:160182016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL,
Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration
and invasion of human A549 lung cancer cells through the inhibition
of matrix metalloproteinase-2 and −9 and Vascular endothelial
growth factor (VEGF). Cancer Lett. 285:127–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Li X, Ma S, Yang P, Sun B, Zhang Y, Sun Y,
Hao M, Mou R and Jia Y: Anticancer effects of curcumin on nude mice
bearing lung cancer A549 cell subsets SP and NSP cells. Oncol Lett.
16:6756–6762. 2018.PubMed/NCBI
|
|
85
|
Ashrafizadeh M, Najafi M, Makvandi P,
Zarrabi A, Farkhondeh T and Samarghandian S: Versatile role of
curcumin and its derivatives in lung cancer therapy. J Cell
Physiol. 235:9241–9268. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Weng W and Goel A: Curcumin and colorectal
cancer: An update and current perspective on this natural medicine.
Semin Cancer Biol. 80:73–86. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Pan Y, Sun Y, Liu Z and Zhang C: miR1925p
upregulation mediates the suppression of curcumin in human NSCLC
cell proliferation, migration and invasion by targeting cMyc and
inactivating the Wnt/βcatenin signaling pathway. Mol Med Rep.
22:1594–1604. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cheng MA, Chou FJ, Wang K, Yang R, Ding J,
Zhang Q, Li G, Yeh S, Xu D and Chang C: Androgen receptor (AR)
degradation enhancer ASC-J9® in an FDA-approved
formulated solution suppresses castration resistant prostate cancer
cell growth. Cancer Lett. 417:182–191. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Dorai T, Cao YC, Dorai B, Buttyan R and
Katz AE: Therapeutic potential of curcumin in human prostate
cancer. III. Curcumin inhibits proliferation, induces apoptosis,
and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
Prostate. 47:293–303. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Mukhopadhyay A, Bueso-Ramos C, Chatterjee
D, Pantazis P and Aggarwal BB: Curcumin downregulates cell survival
mechanisms in human prostate cancer cell lines. Oncogene.
20:7597–7609. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Xie Q, Hu Y, Zhang C, Zhang C, Qin J, Zhao
Y, An Q, Zheng J and Shi C: Curcumin blunts epithelial-mesenchymal
transition to alleviate invasion and metastasis of prostate cancer
through the JARID1D demethylation. Cancer Cell Int. 24:3032024.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li W, Wang F, Wang X, Xu W, Liu F, Hu R
and Li S: Curcumin inhibits prostate cancer by upregulating
miR-483-3p and inhibiting UBE2C. J Biochem Mol Toxicol.
38:e236452024. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen Z, Ni R, Hu Y, Yang Y and Tian Y:
Arnicolide D inhibits proliferation and induces apoptosis of
osteosarcoma cells through PI3K/Akt/mTOR pathway. Anticancer Agents
Med Chem. 24:1288–1294. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Huang SL, Chang TC and Sun NK: Curcumin
reduces paclitaxel resistance in ovarian carcinoma cells by
upregulating SNIP1 and inhibiting NFκB activity. Biochem Pharmacol.
212:1155812023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ismail NI, Othman I, Abas F, Lajis NH and
Naidu R: The curcumin analogue,
MS13(1,5-Bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one),
inhibits cell proliferation and induces apoptosis in primary and
metastatic human colon cancer cells. Molecules. 25:37982020.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Ahmad I, Hoque M, Alam SSM, Zughaibi TA
and Tabrez S: Curcumin and plumbagin synergistically target the
PI3K/Akt/mTOR pathway: A prospective role in cancer treatment. Int
J Mol Sci. 24:66512023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Qiao X, Zheng K, Ye L, Yang J, Cui R, Shan
Y, Li X, Li H, Zhu Q, Zhao Z, et al: NL13, a novel curcumin
analogue and polo like kinase 4 inhibitor, induces cell cycle
arrest and apoptosis in prostate cancer models. Br J Pharmacol.
181:4658–4676. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Li J, Wang X, Xue L and He Q: Exploring
the therapeutic mechanism of curcumin in prostate cancer using
network pharmacology and molecular docking. Heliyon. 10:e331032024.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhu J, Li Q, Wu Z, Xu Y and Jiang R:
Curcumin for treating breast cancer: A review of molecular
mechanisms, combinations with anticancer drugs, and nanosystems.
Pharmaceutics. 16:792024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
El-Far AH, Saddiq AA, Mohamed SA,
Almaghrabi OA and Mousa SA: Curcumin and thymoquinone combination
attenuates breast cancer cell lines' progression. Integr Cancer
Ther. 21:153473542210995372022. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Sarkar E, Kotiya A, Khan A, Bhuyan R, Raza
ST, Misra A and Mahdi AA: The combination of curcumin and
doxorubicin on targeting PI3K/AKT/mTOR signaling pathway: An in
vitro and molecular docking study for inhibiting the survival of
MDA-MB-231. In Silico Pharmacol. 12:582024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Alqahtani AM, Chidambaram K, Pino-Figueroa
A, Chandrasekaran B, Dhanaraj P and Venkatesan K:
Curcumin-Celecoxib: A synergistic and rationale combination
chemotherapy for breast cancer. Eur Rev Med Pharmacol Sci.
25:1916–1927. 2021.PubMed/NCBI
|
|
103
|
Wang X, Zhang L and Si H: Combining
luteolin and curcumin synergistically suppresses triple-negative
breast cancer by regulating IFN and TGF-β signaling pathways.
Biomed Pharmacother. 178:1172212024. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Vahedi F, Javan B, Sharbatkhari M, Soltani
A, Shafiee M, Memarian A and Erfani-Moghadam V: Synergistic
anticancer effects of co-delivery of linc-RoR siRNA and curcumin
using polyamidoamine dendrimers against breast cancer. Biochem
Biophys Res Commun. 705:1497292024. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Palacios-Navarro L, Crispin LA, Muñoz JP
and Calaf GM: Effects of curcumin and estrogen receptor alpha in
luminal breast cancer cells. Diagnostics (Basel). 14:17852024.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Nishimura FG, Sampaio BB, do Couto GO, da
Silva AD, da Silva WJ, Peronni KC, Evangelista AF, Hossain M,
Dimmock JR, Bandy B, et al: The transcriptome of BT-20 Breast
cancer cells exposed to curcumin analog NC2603 reveals a
relationship between EGR3 gene modulation and cell migration
inhibition. Molecules. 29:13662024. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Huai Z, Li Z, Xue W, Li S, Huang Y, Cao X,
Wei Q and Wang Y: Novel curcumin derivatives N17 exert anti-cancer
effects through the CSNK1G3/AKT axis in triple-negative breast
cancer. Biochem Pharmacol. 229:1164722024. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Novitasari D, Nakamae I, Jenie RI,
Yoneda-Kato N, Kato JY and Meiyanto E: Pentagamavunone-1 inhibits
aggressive breast cancer cell proliferation through mitotic
catastrophe and ROS-mediated activities: In vitro and in vivo
studies. Saudi Pharm J. 32:1018922024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Nishimura FG, Sampaio BB, Komoto TT, da
Silva WJ, da Costa MMG, Haddad GI, Peronni KC, Evangelista AF,
Hossain M, Dimmock JR, et al: Exploring CDKN1A upregulation
mechanisms: Insights into cell cycle arrest induced by NC2603
curcumin analog in MCF-7 breast cancer cells. Int J Mol Sci.
25:49892024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Verderio P, Pandolfi L, Mazzucchelli S,
Marinozzi MR, Vanna R, Gramatica F, Corsi F, Colombo M, Morasso C
and Prosperi D: Antiproliferative effect of ASC-J9 delivered by
PLGA nanoparticles against estrogen-dependent breast cancer cells.
Mol Pharm. 11:2864–2875. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Zhang B, Deng Y, Xu D and Zhao X:
Dimethylcurcumin and copper sulfate-loaded silk nanoparticles for
synergistic therapy against breast cancer. ACS Biomater Sci Eng.
11:1539–1548. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Nautiyal J, Banerjee S, Kanwar SS, Yu Y,
Patel BB, Sarkar FH and Majumdar AP: Curcumin enhances
dasatinib-induced inhibition of growth and transformation of colon
cancer cells. Int J Cancer. 128:951–961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Villegas C, Perez R, Sterner O,
González-Chavarría I and Paz C: Curcuma as an adjuvant in
colorectal cancer treatment. Life Sci. 286:1200432021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Liu C, Rokavec M, Huang Z and Hermeking H:
Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress
colorectal cancer metastasis. Cell Death Differ. 30:1771–1785.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sazanov AA, Kiselyova EV, Zakharenko AA,
Romanov MN and Zaraysky MI: Plasma and saliva miR-21 expression in
colorectal cancer patients. J Appl Genet. 58:231–237. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Mudduluru G, George-William JN, Muppala S,
Asangani IA, Kumarswamy R, Nelson LD and Allgayer H: Curcumin
regulates miR-21 expression and inhibits invasion and metastasis in
colorectal cancer. Biosci Rep. 31:185–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Roy S, Yu Y, Padhye SB, Sarkar FH and
Majumdar AP: Difluorinated-curcumin (CDF) restores PTEN expression
in colon cancer cells by down-regulating miR-21. PLoS One.
8:e685432013. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Dal Z and Aru B: The role of curcumin on
apoptosis and NLRP3 inflammasome-dependent pyroptosis on colorectal
cancer in vitro. Turk J Med Sci. 53:883–893. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Hosseini SS, Reihani RZ, Doustvandi MA,
Amini M, Zargari F, Baradaran B, Yari A, Hashemi M, Tohidast M and
Mokhtarzadeh A: Synergistic anticancer effects of curcumin and
crocin on human colorectal cancer cells. Mol Biol Rep.
49:8741–8752. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Kunnumakkara AB, Diagaradjane P, Guha S,
Deorukhkar A, Shentu S, Aggarwal BB and Krishnan S: Curcumin
sensitizes human colorectal cancer xenografts in nude mice to
gamma-radiation by targeting nuclear factor-kappaB-regulated gene
products. Clin Cancer Res. 14:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Reddy S, Rishi AK, Xu H, Levi E, Sarkar FH
and Majumdar AP: Mechanisms of curcumin- and EGF-receptor related
protein (ERRP)-dependent growth inhibition of colon cancer cells.
Nutr Cancer. 55:185–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Sun H, Liao F, Tian Y, Lei Y, Fu Y and
Wang J: Molecular-Scale investigations reveal the effect of natural
polyphenols on BAX/Bcl-2 interactions. Int J Mol Sci. 25:24742024.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Sha J, Li J, Wang W, Pan L, Cheng J, Li L,
Zhao H and Lin W: Curcumin induces G0/G1 arrest and apoptosis in
hormone independent prostate cancer DU-145 cells by down regulating
notch signaling. Biomed Pharmacother. 84:177–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Liao H, Wang Z, Deng Z, Ren H and Li X:
Curcumin inhibits lung cancer invasion and metastasis by
attenuating GLUT1/MT1-MMP/MMP2 pathway. Int J Clin Exp Med.
8:8948–8957. 2015.PubMed/NCBI
|
|
125
|
Mohankumar K, Francis AP, Pajaniradje S
and Rajagopalan R: Synthetic curcumin analog: Inhibiting the
invasion, angiogenesis, and metastasis in human laryngeal carcinoma
cells via NF-kB pathway. Mol Biol Rep. 48:6065–6074. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Fernandez-Muñoz KV, Sánchez-Barrera CÁ,
Meraz-Ríos M, Reyes JL, Pérez-Yépez EA, Ortiz-Melo MT, Terrazas LI
and Mendoza-Rodriguez MG: Natural alternatives in the treatment of
colorectal cancer: A mechanisms perspective. Biomolecules.
15:3262025. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Shadnoush M, Momenan M, Seidel V, Tierling
S, Fatemi N, Nazemalhosseini-Mojarad E, Norooz MT and Cheraghpour
M: A comprehensive update on the potential of curcumin to enhance
chemosensitivity in colorectal cancer. Pharmacol Rep. 77:103–123.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Imtiaz I, Schloss J and Bugarcic A:
Interplay between traditional and scientific knowledge:
Phytoconstituents and their roles in lung and colorectal cancer
signaling pathways. Biomolecules. 15:3802025. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Guo Y, Su J, Jiang S, Xu Y, Dou B, Li T,
Zhu J and He K: Transcriptomics and metabonomics study on the
effect of exercise combined with curcumin supplementation on breast
cancer in mice. Heliyon. 10:e288072024. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Sowa-Kasprzak K, Józkowiak M, Olender D,
Pawełczyk A, Piotrowska-Kempisty H and Zaprutko L:
Curcumin-Triterpene type hybrid as effective sonosensitizers for
sonodynamic therapy in oral squamous cell carcinoma. Pharmaceutics.
15:20082023. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Semlali A, Beji S, Ajala I, Al-Zharani M
and Rouabhia M: Synergistic effects of new curcumin analog (PAC)
and cisplatin on oral cancer therapy. Curr Issues Mol Biol.
45:5018–5035. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Lee AY, Fan CC, Chen YA, Cheng CW, Sung
YJ, Hsu CP and Kao TY: Curcumin inhibits invasiveness and
epithelial-mesenchymal transition in oral squamous cell carcinoma
through reducing matrix metalloproteinase 2, 9 and modulating
p53-E-cadherin pathway. Integr Cancer Ther. 14:484–490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Li Y, Deng X, Tan X, Li Q, Yu Z, Wu W, Ma
X, Zeng J and Wang X: Protective role of curcumin in disease
progression from non-alcoholic fatty liver disease to
hepatocellular carcinoma: a meta-analysis. Front Pharmacol.
15:13431932024. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Man S, Yao J, Lv P, Liu Y, Yang L and Ma
L: Curcumin-enhanced antitumor effects of sorafenib via regulating
the metabolism and tumor microenvironment. Food Funct.
11:6422–6432. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Huang T, Chen H, Pan H, Wu T, Ren X, Qin
L, Yuan K and He F: Comprehensive analysis of bioinformatics and
system biology reveals the association between Girdin and
hepatocellular carcinoma. PLoS One. 19:e03155342024. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Han H, Alsayed AMM, Wang Y, Yan Q, Shen A,
Zhang J, Ye Y, Liu Z, Wang K and Zheng X: Discovery of
β-cyclocitral-derived mono-carbonyl curcumin analogs as
anti-hepatocellular carcinoma agents via suppression of MAPK
signaling pathway. Bioorg Chem. 132:1063582023. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Mukherjee D, Dash P, Ramadass B and
Mangaraj M: Nanocurcumin in oral squamous cancer cells and its
efficacy as a chemo-adjuvant. Cureus. 14:e246782022.PubMed/NCBI
|
|
138
|
Lakshmanan A, Akasov RA, Sholina NV,
Demina PA, Generalova AN, Gangadharan A, Sardar DK, Lankamsetty KB,
Khochenkov DA, Khaydukov EV, et al: Nanocurcumin-loaded UCNPs for
cancer theranostics: Physicochemical properties, in vitro toxicity,
and in vivo imaging studies. Nanomaterials (Basel). 11:22342021.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Louisa M, Wanafri E, Arozal W, Sandhiutami
NMD and Basalamah AM: Nanocurcumin preserves kidney function and
haematology parameters in DMBA-induced ovarian cancer treated with
cisplatin via its antioxidative and anti-inflammatory effect in
rats. Pharm Biol. 61:298–305. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Mehrab H, Sharifi M, Akhavan A, Aarabi MH,
Mansourian M, Mosavi E and Moghaddas A: Curcumin supplementation
prevents cisplatin-induced nephrotoxicity: A randomized,
double-blinded, and placebo-controlled trial. Res Pharm Sci.
18:648–662. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Ramezani V, Ghadirian S, Shabani M,
Boroumand MA, Daneshvar R and Saghafi F: Efficacy of curcumin for
amelioration of radiotherapy-induced oral mucositis: A preliminary
randomized controlled clinical trial. BMC Cancer. 23:3542023.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Eghbali A, Adibifar M, Ghasemi A, Afzal
RR, Moradi K, Eghbali A, Faress F and Ghaffari K: The effect of
oral curcumin on vincristine-induced neuropathy in pediatric acute
lymphoblastic leukemia: A double-blind randomized controlled
clinical trial. BMC Cancer. 25:3442025. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Kekatpure V, Subramaniam N, Sunny S,
Nambiar S, Sarah T, Vasudevan V, Rao A, Murali A, Kolur T,
Krishnamurthy A, et al: Two by two factorial design using metformin
and curcumin for second primary head and neck cancer prevention
trial. Asian Pac J Cancer Prev. 25:1935–1943. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Dahka SM, Afsharfar M, Tajaddod S, Sohouli
MH, Shekari S, Nafouti FB, Alizadeh A, Kachaei HS, Abbasi K,
Mohseni GK, et al: Impact of curcumin supplementation on radiation
dermatitis severity: A systematic review and meta-analysis of
randomized controlled trials. Asian Pac J Cancer Prev. 24:783–789.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Chaiworramukkul A, Seetalarom K,
Saichamchan S and Prasongsook N: A Double-Blind, placebo-controlled
randomized phase IIa study: Evaluating the effect of curcumin for
treatment of cancer anorexia-cachexia syndrome in solid cancer
patients. Asian Pac J Cancer Prev. 23:2333–2340. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Panahi Y, Saberi-Karimian M, Valizadeh O,
Behnam B, Saadat A, Jamialahmadi T, Majeed M and Sahebkar A:
Effects of curcuminoids on systemic inflammation and quality of
life in patients with colorectal cancer undergoing chemotherapy: A
randomized controlled trial. Adv Exp Med Biol. 1328:1–9. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Wei Y, Wei Y, Sheng L, Ma J, Su Z, Wen J,
Li L, Jia Q, Liu H, Si H, et al: Construction of curcumin and
paclitaxel co-loaded lipid nano platform and evaluation of its
anti-hepatoma activity in vitro and pharmacokinetics in vivo. Int J
Nanomedicine. 18:2087–2107. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Guo F, Jiao Y, Ding W, Du Y, Luo S, Wang
M, Wang Y, Wu F, Wang L and Yang G: Synergistic effects of
multidrug/material combination deliver system for
anti-mutidrug-resistant tumor. Int J Pharm. 649:1236692024.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Abe T, Horisawa Y, Kikuchi O, Ozawa-Umeta
H, Kishimoto A, Katsuura Y, Imaizumi A, Hashimoto T, Shirakawa K,
Takaori-Kondo A, et al: Pharmacologic characterization of TBP1901,
a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for
therapeutic targets of aglycone curcumin. Eur J Pharmacol.
935:1753212022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Gutsche LC, Dörfler J and Hübner J:
Curcumin as a complementary treatment in oncological therapy: A
systematic review. Eur J Clin Pharmacol. 81:1–33. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Zeng L, Yang T, Yang K, Yu G, Li J, Xiang
W and Chen H: Efficacy and safety of curcumin and Curcuma
longa extract in the treatment of arthritis: A systematic
review and meta-analysis of randomized controlled trial. Front
Immunol. 13:8918222022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Liu S, Liu J, He L, Liu L, Cheng B, Zhou
F, Cao D and He Y: A comprehensive review on the benefits and
problems of curcumin with respect to human health. Molecules.
27:44002022. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Huang M, Zhai BT, Fan Y, Sun J, Shi YJ,
Zhang XF, Zou JB, Wang JW and Guo DY: Targeted drug delivery
systems for curcumin in breast cancer therapy. Int J Nanomedicine.
18:4275–4311. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Alam MS, Anwar MJ, Maity MK, Azam F,
Jaremko M and Emwas AH: the dynamic role of curcumin in mitigating
human illnesses: Recent advances in therapeutic applications.
Pharmaceuticals (Basel). 17:16742024. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Anand P, Kunnumakkara AB, Newman RA and
Aggarwal BB: Bioavailability of curcumin: Problems and promises.
Mol Pharm. 4:807–818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Gupta SC, Patchva S and Aggarwal BB:
Therapeutic roles of curcumin: Lessons learned from clinical
trials. AAPS J. 15:195–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kanai M, Imaizumi A, Otsuka Y, Sasaki H,
Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H and Chiba T:
Dose-escalation and pharmacokinetic study of nanoparticle curcumin,
a potential anticancer agent with improved bioavailability, in
healthy human volunteers. Cancer Chemother Pharmacol. 69:65–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Mashayekhi-Sardoo H, Mashayekhi-Sardoo A,
Roufogalis BD, Jamialahmadi T and Sahebkar A: Impact of curcumin on
microsomal enzyme activities: Drug interaction and chemopreventive
studies. Curr Med Chem. 28:7122–7140. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Imam Z, Khasawneh M, Jomaa D, Iftikhar H
and Sayedahmad Z: Drug induced liver injury attributed to a
curcumin supplement. Case Rep Gastrointest Med.
2019:60294032019.PubMed/NCBI
|
|
160
|
Lukefahr AL, McEvoy S, Alfafara C and Funk
JL: Drug-induced autoimmune hepatitis associated with turmeric
dietary supplement use. BMJ Case Rep. 2018:bcr20182246112018.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Bhat PA, Chat OA and Dar AA: Exploiting
co-solubilization of warfarin, curcumin, and rhodamine B for
modulation of energy transfer: A micelle FRET On/Off switch.
Chemphyschem. 17:2360–2372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Servida S, Piontini A, Gori F, Tomaino L,
Moroncini G, De Gennaro Colonna V, La Vecchia C and Vigna L:
Curcumin and gut microbiota: A narrative overview with focus on
glycemic control. Int J Mol Sci. 25:77102024. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Jabczyk M, Nowak J, Hudzik B and
Zubelewicz-Szkodzińska B: Curcumin in metabolic health and disease.
Nutrients. 13:44402021. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Lin X, Bai D, Wei Z, Zhang Y, Huang Y,
Deng H and Huang X: Curcumin attenuates oxidative stress in
RAW264.7 cells by increasing the activity of antioxidant enzymes
and activating the Nrf2-Keap1 pathway. PLoS One. 14:e02167112019.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Zhou Y, Jia Z, Wang J, Huang S, Yang S,
Xiao S, Xia D and Zhou Y: Curcumin reverses erastin-induced
chondrocyte ferroptosis by upregulating Nrf2. Heliyon.
9:e201632023. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Zhang J, Sun X, Chai X, Jiao Y, Sun J,
Wang S, Yu H and Feng X: Curcumin mitigates oxidative damage in
broiler liver and ileum caused by aflatoxin B1-contaminated feed
through Nrf2 signaling pathway. Animals (Basel). 14:4092024.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Chen B, Li H, Ou G, Ren L, Yang X and Zeng
M: Curcumin attenuates MSU crystal-induced inflammation by
inhibiting the degradation of IκBα and blocking mitochondrial
damage. Arthritis Res Ther. 21:1932019. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Kooshki L, Zarneshan SN, Fakhri S, Moradi
SZ and Echeverria J: The pivotal role of JAK/STAT and IRS/PI3K
signaling pathways in neurodegenerative diseases: Mechanistic
approaches to polyphenols and alkaloids. Phytomedicine.
112:1546862023. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Grilc NK, Sova M and Kristl J: Drug
delivery strategies for curcumin and other natural Nrf2 modulators
of oxidative stress-related diseases. Pharmaceutics. 13:21372021.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Ruan H, Zeng X and Shen S: Mechanism of
curcumin inhibiting NLRP3 inflammatory body and improving
atherosclerotic endothelial cell injury. Discov Med. 36:121–128.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen
Z, Hu C and Xu R: Anti-Inflammatory effects of curcumin in the
inflammatory diseases: Status, limitations and countermeasures.
Drug Des Devel Ther. 15:4503–4525. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Chen G, Liu S, Pan R, Li G, Tang H, Jiang
M, Xing Y, Jin F, Lin L and Dong J: Curcumin attenuates
gp120-Induced microglial inflammation by inhibiting autophagy via
the PI3K pathway. Cell Mol Neurobiol. 38:1465–1477. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Chowdhury I, Banerjee S, Driss A, Xu W,
Mehrabi S, Nezhat C, Sidell N, Taylor RN and Thompson WE: Curcumin
attenuates proangiogenic and proinflammatory factors in human
eutopic endometrial stromal cells through the NF-κB signaling
pathway. J Cell Physiol. 234:6298–6312. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Li Y, Tan L, Liu F, Li M, Zeng S, Gui Y,
Zhao Y and Wang JJ: Effects of soluble Antarctic krill
protein-curcumin complex combined with photodynamic inactivation on
the storage quality of shrimp. Food Chem. 403:1343882023.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Wang JJ, He T, Chen L, Xu G, Dong S, Zhao
Y, Zheng H, Liu Y and Zeng Q: Antibacterial efficiency of the
curcumin-mediated photodynamic inactivation coupled with L-arginine
against Vibrio parahaemolyticus and its application on shrimp. Int
J Food Microbiol. 411:1105392024. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Bhavya ML and Hebbar HU: Efficacy of blue
LED in microbial inactivation: Effect of photosensitization and
process parameters. Int J Food Microbiol. 290:296–304. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
de Andrade Neto JB, de Farias Cabral VP,
Nogueira LF, da Silva CR, do Amaral Valente Sá LG, da Silva AR, da
Silva WM, Silva J, Marinho ES, Cavalcanti BC, et al: Anti-MRSA
activity of curcumin in planktonic cells and biofilms and
determination of possible action mechanisms. Microb Pathog.
155:1048922021. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
El-Mahdy AM, Alqahtani M, Almukainzi M,
Alghoribi MF and Abdel-Rhman SH: Effect of resveratrol and curcumin
on gene expression of methicillin-resistant staphylococcus aureus
(MRSA) toxins. J Microbiol Biotechnol. 34:141–148. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Zheng D, Huang C, Huang H, Zhao Y, Khan
MRU, Zhao H and Huang L: Antibacterial mechanism of curcumin: A
review. Chem Biodivers. 17:e20001712020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Mounce BC, Cesaro T, Carrau L, Vallet T
and Vignuzzi M: Curcumin inhibits Zika and chikungunya virus
infection by inhibiting cell binding. Antiviral Res. 142:148–157.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Li Y, Wang J, Liu Y, Luo X, Lei W and Xie
L: Antiviral and virucidal effects of curcumin on transmissible
gastroenteritis virus in vitro. J Gen Virol. 101:1079–1084. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Anggakusuma Colpitts CC, Schang LM,
Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ,
Bankwitz D, Steinmann J, et al: Turmeric curcumin inhibits entry of
all hepatitis C virus genotypes into human liver cells. Gut.
63:1137–1149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Thongsri P, Pewkliang Y, Borwornpinyo S,
Wongkajornsilp A, Hongeng S and Sa-Ngiamsuntorn K: Curcumin
inhibited hepatitis B viral entry through NTCP binding. Sci Rep.
11:191252021. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Prasad S and Tyagi AK: Curcumin and its
analogues: A potential natural compound against HIV infection and
AIDS. Food Funct. 6:3412–3419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Zhang HS, Ruan Z and Sang WW: HDAC1/NFκB
pathway is involved in curcumin inhibiting of Tat-mediated long
terminal repeat transactivation. J Cell Physiol. 226:3385–3391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Dai J, Gu L, Su Y, Wang Q, Zhao Y, Chen X,
Deng H, Li W, Wang G and Li K: Inhibition of curcumin on influenza
A virus infection and influenzal pneumonia via oxidative stress,
TLR2/4, p38/JNK MAPK and NF-κB pathways. Int Immunopharmacol.
54:177–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Hesari A, Ghasemi F, Salarinia R, Biglari
H, Hassan AT, Abdoli V and Mirzaei H: Effects of curcumin on NF-κB,
AP-1, and Wnt/β-catenin signaling pathway in hepatitis B virus
infection. J Cell Biochem. 119:7898–7904. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Piccialli I, Tedeschi V, Caputo L,
D'Errico S, Ciccone R, De Feo V, Secondo A and Pannaccione A:
Exploring the therapeutic potential of phytochemicals in
Alzheimer's disease: focus on polyphenols and monoterpenes. Front
Pharmacol. 13:8766142022. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Alamro AA, Alsulami EA, Almutlaq M,
Alghamedi A, Alokail M and Haq SH: Therapeutic potential of vitamin
D and curcumin in an in vitro model of Alzheimer disease. J
Cent Nerv Syst Dis. 12:11795735209243112020. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Yuan J, Botchway BOA, Zhang Y, Tan X, Wang
X and Liu X: Curcumin can improve spinal cord injury by inhibiting
TGF-β-SOX9 signaling pathway. Cell Mol Neurobiol. 39:569–575. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Panzarini E, Mariano S, Tacconi S, Carata
E, Tata AM and Dini L: Novel therapeutic delivery of nanocurcumin
in central nervous system related disorders. Nanomaterials (Basel).
11:22020. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Lee Y, Park HR, Lee JY, Kim J, Yang S, Lee
C, Kim K, Kim HS, Chang SC and Lee J: Low-dose curcumin enhances
hippocampal neurogenesis and memory retention in young mice. Arch
Pharm Res. 46:423–437. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Yavari N, Sharifi ZN, Rekabdar Y and
Movassaghi S: Protective effect of curcumin on CA1 region of
hippocampus in rat model of ischemia/ reperfusion injury. Galen Med
J. 11:e10622022. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Zhang L, Ma Z, Wu Z, Jin M, An L and Xue
F: curcumin improves chronic pain induced depression through
regulating serum metabolomics in a rat model of trigeminal
neuralgia. J Pain Res. 13:3479–3492. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Zhang L, Han Y, Wu X, Chen B, Liu S, Huang
J, Kong L, Wang G and Ye Z: Research progress on the mechanism of
curcumin in cerebral ischemia/reperfusion injury: A narrative
review. Apoptosis. 28:1285–1303. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Racchi M, Uberti D, Govoni S, Memo M,
Lanni C, Vasto S, Candore G, Caruso C, Romeo L and Scapagnini G:
Alzheimer's disease: New diagnostic and therapeutic tools. Immun
Ageing. 5:72008. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Scapagnini G, Colombrita C, Amadio M,
D'Agata V, Arcelli E, Sapienza M, Quattrone A and Calabrese V:
Curcumin activates defensive genes and protects neurons against
oxidative stress. Antioxid Redox Signal. 8:395–403. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Sadek MA, Rabie MA, El Sayed NS, Sayed HM
and Kandil EA: Neuroprotective effect of curcumin against
experimental autoimmune encephalomyelitis-induced cognitive and
physical impairments in mice: An insight into the role of the
AMPK/SIRT1 pathway. Inflammopharmacology. 32:1499–1518. 2024.
View Article : Google Scholar : PubMed/NCBI
|
